DAVID HON: Open Payments
NPI 1740237510 · NEWTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 38 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $175 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $174 |
| Teva Pharmaceuticals USA, Inc. | 5 | $111 |
| Vanda Pharmaceuticals Inc. | 4 | $104 |
| Janssen Pharmaceuticals, Inc | 4 | $103 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
| Neurocrine BioSciences, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Alkermes, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Noven Therapeutics, LLC | 1 | $19 |
Products named: REXULTI, COBENFY, UZEDY, INGREZZA, HETLIOZ, ABILIFY MAINTENA, INVEGA SUSTENNA, SPRAVATO.
Industry payments across KS — which companies pay providers there.
